Hardy Diagnostics introduces NG-Test CARBA 5 for the detection of carbapenemases
Hardy Diagnostics, an FDA-licensed and ISO-certified biomedical manufacturer, has formed a partnership with NG Biotech in France. Hardy Diagnostics is now the United States’ authorized distributor of NG Biotech’s NG-Test CARBA 5, a rapid (15-minute) multiplex immunoassay for the detection and differentiation of the five most common carbapenemases from bacterial culture of Enterobacterales and Pseudomonas aeruginosa. This easy-to-use test has been proven to save microbiologists time by simplifying the process of testing for these resistance enzymes. It also enhances the sensitivity, decreases turnaround time, lowers the overall cost per test and represents a vast process-efficiency improvement over molecular methods.
NG Biotech, an IVD company from Guipry, France, has a history of delivering quality products that utilize multiplex lateral flow technology to many countries in the world that need point-of-care (POC), low-cost and rapid diagnostic solutions.
